Genocea Biosciences Inc (GNCA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

100 ACORN PARK DRIVE CAMBRIDGE, MA 02140

Genocea Biosciences Inc discovers and develops vaccines that address infectious diseases such as pneumococcus, chlamydia trachomatis, malaria, and herpes simplex virus 2.

Data as of 2020-08-01
Market Cap85.399 Million Shares Outstanding29.964 Million Avg 30-day Volume1.652 Million
P/E Ratio Dividend Yield EPS-1.4
Price/Sales94.259 Price cash flow ratio Price free cash flow ratio-2.3
Book Value0.24 Price to Tangible Book14.09 Alpha-0.04
Short Interest Ratio % Short Interest to Float R-squared0.128014
BETA2.38952 52-week High/Low5.75 / 1.1 Stddev0.287344
View SEC Filings from GNCA instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 33 16 (1.05%)
Aggregate 13F shares on 03/31/2020: 13.876 Million 5.931 Million
Aggregate 13F shares on 12/31/2019: 14.807 Million 6.873 Million
Percent change: -6.28% -13.70%
Funds creating new positions: 8 1
Funds Adding to an existing position: 5 4
Funds closing out their position: 9 3
Funds reducing their position: 9 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GNCA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GNCA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

65.5 Million total shares from 22 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLORENCE ANTHONY A. JR.

  • 10% Owner
2,437,689 2020-07-28 1

BASKETT FOREST

  • 10% Owner
2,437,689 2020-07-28 1

MAKOWER JOSHUA

  • 10% Owner
2,437,689 2020-07-28 1

MAKHZOUMI MOHAMAD

  • 10% Owner
2,437,689 2020-07-28 1

SONSINI PETER W.

  • 10% Owner
2,437,689 2020-07-28 1

SANDELL SCOTT D

  • 10% Owner
2,437,689 2020-07-28 1

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
10,376,936 2020-07-24 1

BEHBAHANI ALI

  • Director
  • 10% Owner
10,376,936 2020-07-24 2

CHANG CARMEN

  • 10% Owner
10,376,936 2020-07-24 1

GLAXOSMITHKLINE PLC

  • 10% Owner
4,626,389 2020-07-24 1

WALKER PAUL EDWARD

  • 10% Owner
10,376,936 2020-07-24 1

MOTT DAVID M

  • Director
0 2020-07-01 0

BATE KENNETH

  • Director
0 2020-06-18 1

HIGGINS MICHAEL J

  • Director
0 2020-06-18 1

BOSLEY KATRINE

  • Director
0 2020-06-18 1

SIBER GEORGE

  • Director
0 2020-06-18 1

COOPER RONALD HAROLD WILFRED

  • Director
0 2020-06-18 1

MAYER HOWARD

  • Director
0 2020-06-18 1

HOFFMAN STEPHEN J

  • Director
11,250 2020-06-16 0

SCHWAB GISELA PRES, PROD DEV & MED AFF & CMO

  • Officer
340,843 2020-06-04 3

CLARK WILLIAM D PRESIDENT AND CEO

  • Officer
  • Director
27,344 2020-06-01 2

FLECHTNER JESSICA BAKER CHIEF SCIENTIFIC OFFICER

  • Officer
8,365 2020-06-01 2

BITTERMAN KEVIN

  • Director
0 2020-06-01 0

DAVIS THOMAS ANDREW CHIEF MEDICAL OFFICER

  • Officer
6,623 2020-06-01 2

SINGH NARINDERJEET SENIOR VP, PS&M

  • Officer
8,365 2020-06-01 2

AAKALU GIRISH N CHIEF BUSINESS OFFICER

  • Officer
6,623 2020-06-01 2

DUVALL DIANTHA CHIEF FINANCIAL OFFICER

  • Officer
6,623 2020-06-01 2

BARRIS PETER J

  • Director
6,420 2020-05-27 0

ALFIERI MICHAEL INTERIM HEAD OF FINANCE

  • Officer
0 2020-05-12 0

POOLE JONATHAN CFO

  • Officer
0 2020-01-28 0

MEISNER DEREK M GENERAL COUNSEL

  • Officer
0 2019-11-26 0

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

  • 10% Owner
6,702,399 2019-07-15 0

CARROLL PAMELA SVP IMMUNO-ONCOLOGY

  • Officer
0 2019-02-07 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

PUTTAGUNTA CHETAN

  • Director
0 2018-10-04 0

SAKODA JON

  • 10% Owner
17,783,722 2018-06-27 0

HOFFMAN ERIC S CHIEF BUSINESS OFFICER

  • Officer
0 2018-06-21 0

HETHERINGTON SETH V CHIEF MEDICAL OFFICER

  • Officer
0 2017-02-28 0

GIANNASCA PAUL VP OF DEVELOPMENT

  • Officer
0 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MAKHZOUMI MOHAMAD - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

MAKOWER JOSHUA - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

SONSINI PETER W. - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

WALKER PAUL EDWARD - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

BASKETT FOREST - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

BEHBAHANI ALI - Director - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

FLORENCE ANTHONY A. JR. - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

GLAXOSMITHKLINE PLC - > 10% Owner see footnote

2020-07-24 P 1,260,504 $0.13 a 1,260,504 4,626,389.00 indirect

MAKHZOUMI MOHAMAD - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

SANDELL SCOTT D - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

SONSINI PETER W. - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

NEW ENTERPRISE ASSOCIATES 16, L.P. - > 10% Owner

NEA PARTNERS 16, L.P. - > 10% Owner

NEA 16 GP, LLC - > 10% Owner

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 direct

BASKETT FOREST - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

CHANG CARMEN - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

FLORENCE ANTHONY A. JR. - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

GLAXOSMITHKLINE PLC - > 10% Owner see footnote

2020-07-24 P 1,260,504 $2.25 a 4,626,389 4,626,389.00 indirect

MAKOWER JOSHUA - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

SANDELL SCOTT D - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

WALKER PAUL EDWARD - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

NEW ENTERPRISE ASSOCIATES 16, L.P. - > 10% Owner

NEA PARTNERS 16, L.P. - > 10% Owner

NEA 16 GP, LLC - > 10% Owner

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 direct

BEHBAHANI ALI - Director - > 10% Owner see note 2

2020-07-24 P 3,151,260 $0.13 a 3,151,260 10,376,936.00 indirect

CHANG CARMEN - > 10% Owner see note 2

2020-07-24 P 3,151,260 $2.25 a 10,376,936 10,376,936.00 indirect

SIBER GEORGE - Director

2020-06-18 A 15,000 a 15,000 0.00 direct

BOSLEY KATRINE - Director

2020-06-18 A 15,000 a 15,000 0.00 direct

HIGGINS MICHAEL J - Director

2020-06-18 A 15,000 a 15,000 0.00 direct

BEHBAHANI ALI - Director - > 10% Owner

2020-06-18 A 15,000 a 15,000 0.00 direct

BATE KENNETH - Director

2020-06-18 A 15,000 a 15,000 0.00 direct

COOPER RONALD HAROLD WILFRED - Director

2020-06-18 A 15,000 a 15,000 0.00 direct

MAYER HOWARD - Director

2020-06-18 A 15,000 a 15,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments